S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Sponsor
Southwest Oncology Group (Other)
Overall Status
Completed
CT.gov ID
NCT00012363
Collaborator
National Cancer Institute (NCI) (NIH)
61
96
1
60
0.6
0

Study Details

Study Description

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.

PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have metastatic or recurrent cancer of the esophagus.

Condition or Disease Intervention/Treatment Phase
  • Drug: gemcitabine hydrochloride
  • Drug: irinotecan hydrochloride
Phase 2

Detailed Description

OBJECTIVES:
  • Determine the 6-month survival rate of patients with metastatic or recurrent carcinoma of the esophagus or gastroesophageal junction treated with gemcitabine and irinotecan.

  • Determine the qualitative and quantitative toxic effects of this regimen in these patients.

OUTLINE: Patients receive gemcitabine IV over 30 minutes and irinotecan IV over 90 minutes on days 1 and 8. Treatment repeats every 21 days for at least 6 courses in the absence of disease progression or unacceptable toxicity.

Patients are followed every 3 months for 1 year and then every 6 months for 2 years.

PROJECTED ACCRUAL: A total of 30-55 patients will be accrued for this study.

Study Design

Study Type:
Interventional
Actual Enrollment :
61 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Gemcitabine Plus Irinotecan in Patients With Esophageal Cancer, Phase II
Study Start Date :
Apr 1, 2001
Actual Primary Completion Date :
Apr 1, 2006
Actual Study Completion Date :
Apr 1, 2006

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gemcitabine + Irinotecan

Gemcitabine 1000mg/m2 IV over 30 min on Days 1,8 q21days; Irinotecan 100mg/m2 IV over 90 min on Days 1,8 q21days

Drug: gemcitabine hydrochloride
1,000mg/m2, IV over 30 min, days 1 & 8, q 21 days
Other Names:
  • Gemzar (NSC-613327)
  • Drug: irinotecan hydrochloride
    100 mg/m2, IV over 90 min, days 1 & 8, q 21days
    Other Names:
  • CPT-11 (NSC-616348)
  • Outcome Measures

    Primary Outcome Measures

    1. 6-month survival rate [6 months after registration]

      To assess the six-month survival rate in patients with esophageal cancer treated with a gemcitabine-irinotecan combination chemotherapy regimen.

    Secondary Outcome Measures

    1. Toxicities [Week 1 and Week 2 of each cycle]

      To assess the qualitative and quantitative toxicities associated with this regimen in a Phase II study.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    DISEASE CHARACTERISTICS:
    • Histologically confirmed metastatic or recurrent carcinoma of the esophagus or gastroesophageal junction

    • Squamous cell carcinoma OR

    • Adenocarcinoma

    • No known brain metastases

    PATIENT CHARACTERISTICS:
    Age:
    • 18 to 100
    Performance status:
    • Zubrod 0-2
    Life expectancy:
    • Not specified
    Hematopoietic:
    • Granulocyte count at least 1,500/mm^3

    • Platelet count at least 100,000/mm^3

    Hepatic:
    • Not specified
    Renal:
    • Creatinine no greater than 1.5 times upper limit of normal
    Cardiovascular:
    • No uncontrolled hypertension

    • No unstable angina

    • No symptomatic congestive heart failure

    • No myocardial infarction within the past 6 months

    • No serious uncontrolled cardiac arrhythmia

    Gastrointestinal:
    • No active inflammatory bowel disease

    • No significant bowel obstruction

    • No chronic diarrhea

    Other:
    • Not pregnant or nursing

    • Fertile patients must use effective contraception

    • No active infection requiring systemic therapy

    • No other prior malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or adequately treated stage I or II cancer in complete remission

    PRIOR CONCURRENT THERAPY:
    Biologic therapy:
    • At least 28 days since prior biologic therapy

    • No prior biologic therapy for metastatic or recurrent disease

    • No concurrent sargramostim (GM-CSF)

    • No concurrent immunotherapy for tumor

    Chemotherapy:
    • At least 28 days since prior chemotherapy

    • No prior chemotherapy for metastatic or recurrent disease

    • No prior gemcitabine or irinotecan

    • Prior adjuvant or neoadjuvant chemotherapy at time of initial diagnosis of localized disease allowed

    • No other concurrent chemotherapy for tumor

    Endocrine therapy:
    • See Disease Characteristics

    • At least 28 days since prior endocrine therapy

    • No prior endocrine therapy for metastatic or recurrent disease

    • No concurrent hormonal therapy for tumor

    Radiotherapy:
    • At least 28 days since prior radiotherapy

    • No prior radiotherapy for metastatic or recurrent disease

    • Prior adjuvant or neoadjuvant radiotherapy at time of initial diagnosis of localized disease allowed

    • No concurrent radiotherapy for tumor

    Surgery:
    • Prior thoraco-abdominal surgery allowed

    • At least 3 weeks since prior surgery and recovered

    Other:
    • No other concurrent anti-cancer therapy for tumor

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 MBCCOP - Gulf Coast Mobile Alabama United States 36688
    2 CCOP - Greater Phoenix Phoenix Arizona United States 85006-2726
    3 Veterans Affairs Medical Center - Phoenix (Carl T. Hayden) Phoenix Arizona United States 85012
    4 Veterans Affairs Medical Center - Tucson Tucson Arizona United States 85723
    5 Arizona Cancer Center Tucson Arizona United States 85724
    6 University of Arkansas for Medical Sciences Little Rock Arkansas United States 72205
    7 Veterans Affairs Medical Center - Little Rock (McClellan) Little Rock Arkansas United States 72205
    8 City of Hope Comprehensive Cancer Center Duarte California United States 91010
    9 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California United States 90033-0804
    10 Veterans Affairs Medical Center - West Los Angeles Los Angeles California United States 90073
    11 Jonsson Comprehensive Cancer Center, UCLA Los Angeles California United States 90095-1781
    12 Veterans Affairs Outpatient Clinic - Martinez Martinez California United States 94553
    13 CCOP - Bay Area Tumor Institute Oakland California United States 94609-3305
    14 Chao Family Comprehensive Cancer Center Orange California United States 92868
    15 University of California Davis Medical Center Sacramento California United States 95817
    16 CCOP - Santa Rosa Memorial Hospital Santa Rosa California United States 95403
    17 David Grant Medical Center Travis Air Force Base California United States 94535
    18 University of Colorado Cancer Center Denver Colorado United States 80010
    19 Veterans Affairs Medical Center - Denver Denver Colorado United States 80220
    20 MBCCOP-Howard University Cancer Center Washington District of Columbia United States 20060
    21 CCOP - Atlanta Regional Atlanta Georgia United States 30342-1701
    22 Dwight David Eisenhower Army Medical Center Fort Gordon Georgia United States 30905-5650
    23 Cancer Research Center of Hawaii Honolulu Hawaii United States 96813-2424
    24 Tripler Army Medical Center Honolulu Hawaii United States 96859-5000
    25 MBCCOP - University of Illinois at Chicago Chicago Illinois United States 60612-7323
    26 Veterans Affairs Medical Center - Chicago (Westside Hospital) Chicago Illinois United States 60612
    27 CCOP - Central Illinois Decatur Illinois United States 62526
    28 Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines Illinois United States 60141
    29 Loyola University Medical Center Maywood Illinois United States 60153
    30 University of Kansas Medical Center Kansas City Kansas United States 66160-7353
    31 CCOP - Wichita Wichita Kansas United States 67214-3882
    32 Veterans Affairs Medical Center - Wichita Wichita Kansas United States 67218
    33 Veterans Affairs Medical Center - Lexington Lexington Kentucky United States 40502-2236
    34 Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky United States 40536-0084
    35 MBCCOP - LSU Health Sciences Center New Orleans Louisiana United States 70112
    36 Tulane University School of Medicine New Orleans Louisiana United States 70112
    37 Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana United States 71130-3932
    38 Veterans Affairs Medical Center - Shreveport Shreveport Louisiana United States 71130
    39 Boston Medical Center Boston Massachusetts United States 02118
    40 Veterans Affairs Medical Center - Boston (Jamaica Plain) Jamaica Plain Massachusetts United States 02130
    41 Veterans Affairs Medical Center - Ann Arbor Ann Arbor Michigan United States 48105
    42 CCOP - Ann Arbor Regional Ann Arbor Michigan United States 48106
    43 University of Michigan Comprehensive Cancer Center Ann Arbor Michigan United States 48109-0912
    44 Barbara Ann Karmanos Cancer Institute Detroit Michigan United States 48201-1379
    45 Veterans Affairs Medical Center - Detroit Detroit Michigan United States 48201-1932
    46 Henry Ford Hospital Detroit Michigan United States 48202
    47 CCOP - Grand Rapids Clinical Oncology Program Grand Rapids Michigan United States 49503
    48 CCOP - Beaumont Royal Oak Michigan United States 48073-6769
    49 Providence Hospital - Southfield Southfield Michigan United States 48075-9975
    50 CCOP - Duluth Duluth Minnesota United States 55805
    51 Veterans Affairs Medical Center - Biloxi Biloxi Mississippi United States 39531-2410
    52 University of Mississippi Medical Center Jackson Mississippi United States 39216-4505
    53 Veterans Affairs Medical Center - Jackson Jackson Mississippi United States 39216
    54 Keesler Medical Center - Keesler AFB Keesler AFB Mississippi United States 39534-2576
    55 Veterans Affairs Medical Center - Kansas City Kansas City Missouri United States 64128
    56 CCOP - Kansas City Kansas City Missouri United States 64131
    57 St. Louis University Health Sciences Center Saint Louis Missouri United States 63110
    58 CCOP - St. Louis-Cape Girardeau Saint Louis Missouri United States 63141
    59 CCOP - Cancer Research for the Ozarks Springfield Missouri United States 65807
    60 CCOP - Montana Cancer Consortium Billings Montana United States 59101
    61 Veterans Affairs Medical Center - Albuquerque Albuquerque New Mexico United States 87108-5138
    62 MBCCOP - University of New Mexico HSC Albuquerque New Mexico United States 87131
    63 Veterans Affairs Medical Center - Albany Albany New York United States 12208
    64 Herbert Irving Comprehensive Cancer Center New York New York United States 10032
    65 University of Rochester Medical Center Rochester New York United States 14642
    66 CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina United States 27104-4241
    67 Veterans Affairs Medical Center - Cincinnati Cincinnati Ohio United States 45220-2288
    68 Barrett Cancer Center, The University Hospital Cincinnati Ohio United States 45267-0501
    69 Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States 44195-9001
    70 CCOP - Columbus Columbus Ohio United States 43206
    71 Veterans Affairs Medical Center - Dayton Dayton Ohio United States 45428
    72 CCOP - Dayton Kettering Ohio United States 45429
    73 Oklahoma Medical Research Foundation Oklahoma City Oklahoma United States 73104
    74 Veterans Affairs Medical Center - Oklahoma City Oklahoma City Oklahoma United States 73104
    75 Veterans Affairs Medical Center - Portland Portland Oregon United States 97207
    76 CCOP - Columbia River Program Portland Oregon United States 97225
    77 OHSU Cancer Institute Portland Oregon United States 97239
    78 Veterans Affairs Medical Center - Charleston Charleston South Carolina United States 29401-5799
    79 Medical University of South Carolina Charleston South Carolina United States 29425-0721
    80 CCOP - Greenville Greenville South Carolina United States 29615
    81 CCOP - Upstate Carolina Spartanburg South Carolina United States 29303
    82 Brooke Army Medical Center Fort Sam Houston Texas United States 78234-6200
    83 University of Texas Medical Branch Galveston Texas United States 77555-0565
    84 University of Texas - MD Anderson Cancer Center Houston Texas United States 77030-4095
    85 Veterans Affairs Medical Center - Houston Houston Texas United States 77030
    86 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78284-7845
    87 Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas United States 78284
    88 Veterans Affairs Medical Center - Temple Temple Texas United States 76504
    89 CCOP - Scott and White Hospital Temple Texas United States 76508
    90 Huntsman Cancer Institute Salt Lake City Utah United States 84112-5550
    91 Veterans Affairs Medical Center - Salt Lake City Salt Lake City Utah United States 84148
    92 CCOP - Virginia Mason Research Center Seattle Washington United States 98101
    93 Swedish Cancer Institute Seattle Washington United States 98104
    94 Veterans Affairs Medical Center - Seattle Seattle Washington United States 98108
    95 CCOP - Northwest Tacoma Washington United States 98405-0986
    96 Madigan Army Medical Center Tacoma Washington United States 98431-5000

    Sponsors and Collaborators

    • Southwest Oncology Group
    • National Cancer Institute (NCI)

    Investigators

    • Study Chair: Stephen K. Williamson, MD, University of Kansas

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Southwest Oncology Group
    ClinicalTrials.gov Identifier:
    NCT00012363
    Other Study ID Numbers:
    • CDR0000068515
    • S0101
    • U10CA032102
    First Posted:
    Jan 27, 2003
    Last Update Posted:
    Jun 14, 2012
    Last Verified:
    Jun 1, 2012

    Study Results

    No Results Posted as of Jun 14, 2012